Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Chest|December 1, 1990
Inhaled albuterol and oral prednisone therapy in hospitalized adult asthmatics. Does aminophylline add any benefit?T H Self, N Abou-Shala, R Burns, et al.
Clinical Pharmacology and Therapeutics|March 1, 1983
Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusionW E Evans, P R Hutson, C F Stewart, et al.
Drug Intelligence & Clinical Pharmacy|November 1, 1982
Disposition of intermediate-dose methotrexate in children with acute lymphocytic leukemiaW E Evans, C F Stewart, P R Hutson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenograftsM N Kirstein, P J Houghton, P J Cheshire, et al.
Anti-Cancer Drugs|April 1, 1997
Efficacy of oral irinotecan against neuroblastoma xenograftsJ Thompson, W C Zamboni, P J Cheshire, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
The effect of prior cisplatin therapy on the pharmacokinetics of high-dose methotrexateW R Crom, C B Pratt, A A Green, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1992
Differences in teniposide disposition and pharmacodynamics in patients with newly diagnosed and relapsed acute lymphocytic leukemiaW E Evans, J H Rodman, M V Relling, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 26, 2013
Deriving therapies for children with primary CNS tumors using pharmacokinetic modeling and simulation of cerebral microdialysis dataM O Jacus, S L Throm, D C Turner, et al.
Cancer Research|August 17, 2000
Activation of CPT-11 in mice: identification and analysis of a highly effective plasma esteraseC L Morton, M Wierdl, L Oliver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenograftsW C Zamboni, P J Houghton, J Thompson, et al.
Pageof 9